Product: NantHealth

Filter

Thought Leadership

Product

Organization

NantHealth
NantOmics and NantHealth Announce Results of Proprietary Machine...
Study Published In Breast Cancer Research Shows How Deep-Learning Of Over 650 Breast Cancer Digital Pathology Images And Omics Data...
NantHealth
NantHealth
NantHealth and NantOmics Announce GPS Cancer® Platform May...
Findings Presented at the ASCO-SITC 2020 Clinical Immuno-Oncology Symposium Orlando, FL and Culver City, CA – February 19, 2020 –...
NantHealth
Mark Mozley Headshot with arms crossed
Welcome to the NantHealth Blog
Now, more than ever, healthcare systems around the world are under tremendous pressure. You may be feeling this too. Technological...
NantHealth
Megan Headshot
Employee Spotlight: Megan Salmon-Gardell, RN
Knowledgeable, caring, inspiring, a great leader, and mentor. These are the words used to describe Eviti Senior Director of Clinical...
NantHealth
NantHealth
NantHealth Completes Sale of Connected Care Business to...
Culver City, CA – February 4, 2020: NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare technology company, today announced it...
NantHealth
TRADESHOW: HIMSS20 Global Health Conference & Exhibition
HIMSS20 is the leading health information & technology conference, bringing together nearly 45k professionals from 90+ countries for the education,...
NantHealth
NantHealth
NantHealth and NantOmics Reveal a Novel AI Based...
Derived from deep-learning models, the findings demonstrate novel AI methods of identifying tumor-infiltrating lymphocytes (TILs) in lung cancers Burlingame, CA...
NantHealth
NantHealth
Masimo to Acquire Connected Care Business from NantHealth
Irvine and Culver City, California — January 14, 2020: Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, and NantHealth,...
NantHealth
Precision Insights
NantHealth Presents Research Demonstrating Real World Evidence of...
Eviti Connect study showed an increase in clinical uptake of practice-changing data San Antonio, TX – December 11, 2019 –...
Precision Insights
Precision Insights
NantHealth Announces FDA Marketing Authorization of Omics CoreSM:...
Landmark FDA clearance of whole exome sequencing in vitro diagnostic (IVD) test reporting overall tumor mutation burden (TMB) by sequencing...
Precision Insights
NantHealth
NantHealth Reports 2019 Third-Quarter Financial Results
Q3 Financial Highlights: Total revenue was $22.4 million SaaS revenue was $18.3 million, up 15% from Q3 2018 Total gross...
NantHealth
NantHealth
NantHealth to Report 2019 Third-Quarter Financial Results and...
Culver City, Calif. – October 30, 2019 — NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced...
NantHealth